Trulieve Cannabis Corp
Change company Symbol lookup
Select an option...
TCNNF Trulieve Cannabis Corp
VFFVX Vanguard Target Retirement 2055 Fund Investor Shares
LUB Luby's Inc
AZO Autozone Inc
RMAX Re/Max Holdings Inc
SWET Athlon Acquisition Corp
ETR Entergy Corp
KUBTY Kubota Corp
PTEN Patterson-UTI Energy Inc
LCII LCI Industries
Go

Health Care : Pharmaceuticals | Small Cap Growth
Company profile

Trulieve Cannabis Corp is a Canada-based seed to sale licensed medical cannabis company. The Company cultivates and produces all of its products in-house and distributes those products to Trulieve branded stores (dispensaries), as well as directly to patients through home delivery. It also operates in California, Massachusetts, Connecticut and Pennsylvania. The Company offers a range of products, such as concentrates, flower, oil, capsules and tinctures. It operates cultivation and processing facility in McKeesport, Pennsylvania. It operates three dispensaries, located in Pittsburgh-area locations and also offers medical marijuana relief solutions for Pennsylvanians certified with serious medical conditions. The Company's subsidiaries include PurePenn LLC, Pioneer Leasing & Consulting LLC and Keystone Relief Centers LLC.

Postmarket

Last Trade
Delayed
$37.50
0.00 (0.00%)
Bid
--
Ask
--
B/A Size
--

Market Hours

Closing Price
$37.50
Day's Change
-1.50 (-3.85%)
Bid
--
Ask
--
B/A Size
--
Day's High
39.31
Day's Low
36.25
Volume
(Heavy Day)
Volume:
761,879

10-day average volume:
434,050
761,879

UPDATE: U.S. COVID vaccine program enters new phase as feds deliver jabs directly to drug store chains

2:51 pm ET February 12, 2021 (MarketWatch)
Print

Ciara Linnane

Program aims to get more jabs into arms as new variants circulate

The U.S. vaccine program will enter a new phase Friday when the federal government starts to deliver doses directly to drugstore chains and pharmacies, in an effort to get more jabs into arms as new variants of the virus continue to spread.

The program involves 21 national pharmacy partners and independent pharmacy networks, according to the Centers for Disease Control and Prevention, (https://www.cdc.gov/vaccines/covid-19/retail-pharmacy-program/participating-pharmacies.html)and household names such as Walgreens (WBA), CVS (CVS), Rite Aid (https://www.marketwatch.com/story/rite-aid-stores-to-receive-100-covid-19-vaccines-a-week-in-5-states-and-new-york-city-philadelphia-2021-02-11)(RAD), Walmart (WMT), Kroger (KR) and Costco. (COST)

The initial plan is to send a million doses to 6,500 pharmacies, White House officials said this week. The program is expected to greatly expand the number of sites that offer vaccines and speed up the overall program.

President Joe Biden said Thursday that the U.S. will have enough supply of the COVID-19 vaccine by the end of the summer to inoculate 300 million Americans, the Associated Press reported (https://www.marketwatch.com/story/biden-says-u-s-is-ahead-of-pace-will-have-vaccines-for-300-million-americans-by-end-of-july-01613083700?mod=home-page).

Biden made the announcement at the sprawling National Institutes of Health complex just outside Washington as he visited some of the nation's leading scientists on the front lines of the fight against the disease. He toured the Viral Pathogenesis Laboratory that created the COVID-19 vaccine now manufactured by Moderna (MRNA)and being rolled out in the U.S. and other countries.

Moderna and Pfizer Inc. (PFE) and German partner BioNTech SE (BNTX) confirmed they are supplying the U.S. with another 100 million doses of their two-dose vaccines. There are also hopes that the one-dose vaccine developed by Johnson & Johnson (JNJ) will be granted emergency use authorization as soon as regulators have examined the data from its late-state trial.

Also read: FDA schedules advisory committee for J&J's COVID-19 vaccine candidate for Feb. 26 (https://www.marketwatch.com/story/fda-schedules-advisory-committee-for-jjs-covid-19-vaccine-candidate-for-feb-26-2021-02-05).

The U.S. is on pace to exceed Biden's goal of administering 100 million vaccine doses in his first 100 days in office. The CDC's vaccine tracker (https://covid.cdc.gov/covid-data-tracker/#vaccinations)is showing that as of 6 a.m. ET Thursday, 46 million doses had been administered and 68 million doses had been delivered to states.

"That's just the floor," Biden said. "Our end goal is beating COVID-19."

(https://twitter.com/bhrenton/status/1360013133872570373)

Read now: (https://www.marketwatch.com/story/the-u-s-is-getting-plenty-of-covid-19-vaccines-but-you-still-wont-have-a-normal-summer-11613135830?mod=home-page)The U.S. is getting plenty of COVID-19 vaccines, but you still won't have a normal summer (https://www.marketwatch.com/story/the-u-s-is-getting-plenty-of-covid-19-vaccines-but-you-still-wont-have-a-normal-summer-11613135830?mod=home-page)

The U.S. added another 105,600 new infections of COVID on Thursday, according to a New York Times tracker, (https://www.nytimes.com/interactive/2020/us/coronavirus-us-cases.html?name=styln-coronavirus-live&region=TOP_BANNER&block=storyline_menu_recirc&action=click&pgtype=LegacyCollection&impression_id=&variant=1_Show)exceeding 100,000 for the first time this week. Cases are trending downward, however. The U.S. averaged 101,668 new cases a day in the last week, down 36% from two weeks ago.

Fatalities remain at high levels, with at least 3,878 patients dying on Thursday, although they are also falling, according to the COVID Tracking Project (https://covidtracking.com/analysis-updates/third-surge-continues-to-ease-weekly-covid-19-data-feb-11).

"Nationally, all signs point to continued rapid easing of the pandemic's deadly winter surge," the COVID Tracking Project wrote in its weekly update. "Cases are down 23 percent from the previous week and down 57 percent from the country's all-time peak in early January when the US recorded 1.7 million new cases in a single week.

"Hospitalization numbers confirm this rapid decline: There are about 77,000 people hospitalized with COVID-19 in the US as of February 10, down 42 percent from the country's January 6 record of about 132,000 people. Reported deaths dropped for the second week in a row, with 19,266 deaths reported this week--almost 10% fewer than were reported in the previous week," said the update.

-- Melbourne, Australia's second-largest city, will begin its third lockdown on Friday due to a rapidly spreading COVID-19 cluster centered on hotel quarantine, the AP reported. (https://www.marketwatch.com/story/melbourne-again-on-lockdown-after-new-coronavirus-cluster-01613103551?mod=home-page)The five-day lockdown will be enforced across Victoria state to prevent the virus spreading from the state capital, Victorian Premier Daniel Andrews said. The Australian Open tennis tournament will be allowed to continue but without spectators, he said. Only international flights that were already in the air when the lockdown was announced will be allowed to land at Melbourne Airport. Schools and many businesses will be closed. Residents are ordered to stay at home except to exercise and for essential purposes.

-- Hungary will become the first European Union country to start vaccinating people with Russia's Sputnik V COVID-19 vaccine in the near term, France 24 reported. (https://www.france24.com/en/europe/20210212-hungary-to-start-covid-19-vaccinations-with-russia-s-sputnik-v-bypassing-eu-regulator)Surgeon General Cecilia Muller said the first 2,800 doses of Sputnik (https://www.france24.com/en/europe/20210203-russia-aims-to-boost-production-of-sputnik-covid-19-vaccine-abroad) would be given to those who have registered for inoculations, and that as Hungary was striving for "maximum safety" those who have a chronic disease will not get the shot. Hungarian regulators granted the shot an emergency use authorization before waiting for the European Medicines Agency to do so.

-- The U.K. economy suffered its biggest slump in 300 years in 2020, according to official estimates, demonstrating the toll taken by the country with the worst death toll in Europe, according to data aggregated by Johns Hopkins University. (https://coronavirus.jhu.edu/map.html)Gross domestic product shrank 9.9% over the year as a whole, the Office for National Statistics said Friday, the largest decline among the Group of Seven advanced economies, The Wall Street Journal reported. (https://www.marketwatch.com/story/uk-economy-sees-biggest-slump-in-300-years-2021-02-12)France's economy shrank 8.3% and Italy's contracted 8.8%, according to provisional estimates. German GDP declined 5%. The U.K. has had more than 4 million confirmed cases of COVID, and at least 115,748 people have died, the fifth highest rate in the world.

See also:Just 0.5% of U.S. companies mandate COVID-19 vaccination for all employees (https://www.marketwatch.com/story/just-0-5-of-u-s-companies-mandate-covid-19-vaccination-for-all-employees-11612928585?mod=coronavirus)

-- Walt Disney Co.'s streaming service, Disney+, proved again to be a big plus during a pandemic that has all but shuttered the Magic Kingdom's other businesses, MarketWatch's Jon Swartz reported. A surge in Disney+ subscriptions, to 94.9 million, led a revenue rebound in the company's latest quarter from the previous quarter as the media giant continues to double-down on direct-to-consumer sales. Disney (DIS)reported (https://thewaltdisneycompany.com/app/uploads/2021/02/q1-fy21-earnings.pdf) a surprise fiscal first-quarter profit of $17 million, or 2 cents a share, on sales of $16.25 billion, up from $15.8 billion in the year-ago quarter. After adjusting for restructuring charges and other effects, Disney reported earnings of 32 cents a share, down from $1.53 a share in the year-ago quarter. Analysts on average expected Disney to report an adjusted loss of 34 cents a share on sales of $15.9 billion, according to FactSet.

-- Germany is banning travel from Czech border regions and the Austrian Tyrol to protect itself against a surge of new cases including more infectious variants, the Guardian reported (https://www.theguardian.com/world/live/2021/feb/12/coronavirus-live-news-biden-says-trump-did-not-do-his-job-amazon-variant-three-times-more-contagious?page=with:block-6025db1f8f08d7b7c03d0991#block-6025db1f8f08d7b7c03d0991). The news was announced by Interior Minister Horst Seehofer, who said it has been agreed with Chancellor Angela Merkel. The interior ministry said on Twitter that checkpoints would be put in place, though certain exceptions were expected, including to maintain commercial links.

Read also:Some hospitals are giving wealthy donors early COVID-19 vaccinations -- and that could damage trust in health care at a critical time (https://www.marketwatch.com/story/some-wealthy-hospital-donors-received-early-covid-19-vaccinations-those-institutions-have-a-wide-variety-of-explanations-11613025383?mod=coronavirus)

The global tally for confirmed cases of the coronavirus that causes COVID-19 climbed above 108 million on Friday, the Johns Hopkins data shows, and the death toll rose above 2.37 million.

The U.S. has the highest case tally in the world at 27.4 million and the highest death toll at 479,458, or about a fifth of the global total.

Brazil has the second highest death toll at 236,201 and is third by cases at 9.7 million.

India is second worldwide in cases with 10.9 million, and now fourth in deaths at 155,447.

Mexico has the third highest death toll at 171,234 and 13th highest case tally at 1.9 million.

The U.K. has 4 million cases and 116,507 deaths, the highest in Europe and fifth highest in the world.

2021-02-12 19:51:00 GMT MW UPDATE: U.S. COVID vaccine program enters new -2-

China, where the virus was first discovered late last year, (https://www.marketwatch.com/story/the-coronavirus-from-wuhan-china-now-has-a-name-covid-19-2020-02-11?mod=article_inline) has had 100,551 confirmed cases and 4,828 deaths, according to its official numbers.

Pessimism about financial security, especially among lower-income Americans, grew in early February and fewer expect the economy to show much improvement by the summer, a new survey showed, MarketWatch's Jeffry Bartash reported (https://www.marketwatch.com/story/consumer-sentiment-sags-to-six-month-low-in-february-as-lower-income-americans-grow-more-pessimistic-11613143680?mod=mw_latestnews).

The first of two readings of consumer sentiment this month fell 3.5 points to 76.2 in early February and touched a six-month low, according to an index produced by the University of Michigan. The index registered 79 in January.

Economists polled by Dow Jones and The Wall Street Journal had forecast the index would creep higher to 80.8.

MarketWatch special : The coronavirus pandemic has remade our working lives, and it's been anything but fair (https://www.marketwatch.com/graphics/k-shaped-recovery/).

The economy sputtered toward the end of last year after the record rise in coronavirus cases, but it's still expanding. Growth is expected to accelerate later this year as more Americans get vaccinated, Covid cases decline and Washington pumps more federal aid into the economy.

The Democratic-led Congress is on track to pass nearly $2 trillion in additional stimulus in the next month or so.

Read: Rising inflation is no threat to the U.S. economy -- or is it? (https://www.marketwatch.com/story/rising-inflation-is-no-threat-to-the-u-s-economy-or-is-it-11612560324)

The Dow Jones Industrial Average fell and S&P 500 rose slightly in Friday trades. (https://www.marketwatch.com/story/stock-futures-edge-lower-after-s-p-500-notches-record-close-11613132014?mod=home-page)

-Ciara Linnane; 415-439-6400; AskNewswires@dowjones.com

	

(END) Dow Jones Newswires

February 12, 2021 14:51 ET (19:51 GMT)

Copyright (c) 2021 Dow Jones & Company, Inc.

Earnings Calendar and Events Data provided by |Terms of Use| © 2021 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2021. All rights reserved.